Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Cellular autophagy induction" refers to the **initiation phase** of the cellular process known as **autophagy**, a conserved lysosome-dependent degradation pathway that removes damaged organelles, misfolded proteins, and other cytoplasmic components. This process is essential for maintaining cellular homeostasis, especially under stress conditions such as nutrient deprivation. The induction step is regulated by several signaling pathways—most notably by the inhibition of mTORC1 in response to starvation or stress—which leads to activation of kinase complexes such as ULK1/Atg1. These complexes then recruit downstream effectors necessary for forming the double-membrane structure called an **autophagosome**. While "autophagy induction" is a critical regulatory event with therapeutic implications in diseases like cancer and neurodegeneration, it is not itself a discrete molecular target but rather describes an upstream regulatory phase involving multiple proteins and signaling cascades[1][2][3]. > There is something incorrect about this entry as a "target": "Cellular autophagy induction" describes a biological process or regulatory event rather than a specific molecule or druggable target such as an enzyme or receptor. For structured data purposes, it should be mapped instead to one or more specific protein targets involved in this phase—such as ULK1 kinase complex components—or classified under broader pathway/process categories rather than treated as an individual molecular entity[2].
mTOR inhibition to activate ULK/Atg1 complex for initiation of autophagosome formation
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular autophagy induction.